DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE

« Back to Dashboard

All Clinical Trials for Sildenafil Citrate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00123162	Viagra in the Treatment of Primary Dysmenorrhea	Completed	National Institutes of Health (NIH)	Phase 1/Phase 2	2007-05-01	The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.
NCT00123162	Viagra in the Treatment of Primary Dysmenorrhea	Completed	Milton S. Hershey Medical Center	Phase 1/Phase 2	2007-05-01	The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.
NCT00141310	Sildenafil Citrate for the Treatment of Established Pre-Eclampsia	Terminated	Pfizer	Phase 2	2004-09-01	To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	Beth Israel Medical Center	Phase 3	2005-02-01	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	Icahn School of Medicine at Mount Sinai	Phase 3	2005-02-01	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	St. Luke's-Roosevelt Hospital Center	Phase 3	2005-02-01	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	Memorial Sloan Kettering Cancer Center	Phase 3	2005-02-01	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.

Clinical Trial Conditions for Sildenafil Citrate

Condition Name

Condition Name for Sildenafil Citrate
Intervention	Trials
Erectile Dysfunction	17
Impotence	11
Pulmonary Arterial Hypertension	7
Pulmonary Hypertension	6

Condition MeSH

Condition MeSH for Sildenafil Citrate
Intervention	Trials
Erectile Dysfunction	29
Hypertension	17
Hypertension, Pulmonary	11
Familial Primary Pulmonary Hypertension	10

Clinical Trial Locations for Sildenafil Citrate

Trials by Country

Trials by Country for Sildenafil Citrate
Location	Trials
United States	150
United Kingdom	33
Egypt	15
Japan	13
Brazil	12

Trials by US State

Trials by US State for Sildenafil Citrate
Location	Trials
Texas	11
California	10
Massachusetts	9
North Carolina	8
New York	8

Clinical Trial Progress for Sildenafil Citrate

Clinical Trial Phase

Clinical Trial Phase for Sildenafil Citrate
Clinical Trial Phase	Trials
Phase 4	30
Phase 3	20
Phase 2/Phase 3	5

Clinical Trial Status

Clinical Trial Status for Sildenafil Citrate
Clinical Trial Phase	Trials
Completed	58
Recruiting	19
Not yet recruiting	14

Clinical Trial Sponsors for Sildenafil Citrate

Sponsor Name

Sponsor Name for Sildenafil Citrate
Sponsor	Trials
Pfizer	35
Ain Shams University	7
Assiut University	4

Sponsor Type

Sponsor Type for Sildenafil Citrate
Sponsor	Trials
Other	89
Industry	48
NIH	5